Autologous hematopoietic stem cells transplantation vs Alemtuzumab and Ocrelizumab in Multiple Sclerosis: a real-world comparison

被引：0
|
作者：
Zito, Antonio [1 ]
Signori, Alessio [2 ]
Sormani, Maria Pia [2 ]
Polidoro, Federica [3 ]
Nicholas, Richard [3 ]
Muraro, Paolo [3 ]
Scalfari, Antonio [3 ]
机构：
[1] Mondino, Med, Pavia, Italy
[2] Genoa univ, Genoa, Italy
[3] Imperial Coll London, Ctr Neurosci, Med, London, England
来源：
MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O071/1507
引用
收藏
页码：53 / 53
页数：1
相关论文
共 50 条
  • [31] Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
    Bonaventura Casanova
    Isidro Jarque
    Francisco Gascón
    Juan Carlos Hernández-Boluda
    Francisco Pérez-Miralles
    Javier de la Rubia
    Carmen Alcalá
    Jaime Sanz
    Javier Mallada
    Angeles Cervelló
    Arantxa Navarré
    María Carcelén-Gadea
    Isabel Boscá
    Sara Gil-Perotin
    Carlos Solano
    Miguel Angel Sanz
    Francisco Coret
    Neurological Sciences, 2017, 38 : 1213 - 1221
  • [32] Autologous hematopoietic stem cell transplantation is superior to alemtuzumab in patients with highly active relapsing multiple sclerosis and severe disability
    Vaisvilas, Mantas
    Kaubrys, Gintaras
    Kizlaitiene, Rasa
    Taluntiene, Vera
    Giedraitiene, Natasa
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 80
  • [33] Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
    Casanova, Bonaventura
    Jarque, Isidro
    Gascon, Francisco
    Carlos Hernandez-Boluda, Juan
    Perez-Miralles, Francisco
    de la Rubia, Javier
    Alcala, Carmen
    Sanz, Jaime
    Mallada, Javier
    Cervello, Angeles
    Navarre, Arantxa
    Carcelen-Gadea, Maria
    Bosca, Isabel
    Gil-Perotin, Sara
    Solano, Carlos
    Angel Sanz, Miguel
    Coret, Francisco
    NEUROLOGICAL SCIENCES, 2017, 38 (07) : 1213 - 1221
  • [34] A Real World Data of Ocrelizumab in Multiple Sclerosis
    Beckmann, Y.
    Uzunkopru, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 671 - 671
  • [35] Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
    Carmen Alcalá
    Carlos Quintanilla-Bordás
    Francisco Gascón
    Ángel Perez Sempere
    Laura Navarro
    María Carcelén-Gadea
    Lamberto Landete
    Javier Mallada
    Emmanuel Cañizares
    Antonio Belenguer
    Sara Carratalá
    José Andrés Domínguez
    Francisco Carlos Pérez-Miralles
    Sara Gil-Perotín
    Raquel Gasqué
    Laura Cubas
    Jéssica Castillo
    Bonaventura Casanova
    Journal of Neurology, 2022, 269 : 3676 - 3681
  • [36] Ocrelizumab real-world safety and effectiveness in the two years of treatment in multiple sclerosis
    Vollmer, B.
    Declusin, A.
    Nair, K.
    Sillau, S.
    Corboy, J.
    Vollmer, T.
    Alvarez, E.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 294 - 295
  • [37] Switching from ocrelizumab to ofatumumab in multiple sclerosis: a monocenter real-world experience
    Axhausen, Franziska
    Baumgart, Romy
    Winter, Pia
    Mueck, Anna
    Huttner, Hagen
    Wolff, Stephanie
    Pfeuffer, Steffen
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1099 - 1100
  • [38] Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
    Alcala, Carmen
    Quintanilla-Bordas, Carlos
    Gascon, Francisco
    Sempere, Angel Perez
    Navarro, Laura
    Carcelen-Gadea, Maria
    Landete, Lamberto
    Mallada, Javier
    Canizares, Emmanuel
    Belenguer, Antonio
    Carratala, Sara
    Dominguez, Jose Andres
    Perez-Miralles, Francisco Carlos
    Gil-Perotin, Sara
    Gasque, Raquel
    Cubas, Laura
    Castillo, Jessica
    Casanova, Bonaventura
    JOURNAL OF NEUROLOGY, 2022, 269 (07) : 3676 - 3681
  • [39] Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain
    Sempere, A.
    Berenguer-Ruiz, L.
    Burgos-San Jose, A.
    Aragones, M.
    Navarro-Lopez, M. D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 553 - 553
  • [40] Ocrelizumab use in multiple sclerosis: a real-world experience in a changing therapeutic scenario
    Lorefice, Lorena
    Mellino, Paolo
    Frau, Jessica
    Coghe, Giancarlo
    Fenu, Giuseppe
    Cocco, Eleonora
    NEUROLOGICAL SCIENCES, 2024, 45 (08) : 3951 - 3959
12345